MyAverix Finance
ST · Healthcare
Hansa Biopharma AB (HNSA)
Biotechnology
Hansa Biopharma AB (HNSA) is listed on ST in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HNSA
Hansa Biopharma AB (HNSA) — FAQ
What is HNSA's P/E ratio?
The price-to-earnings (P/E) ratio for Hansa Biopharma AB (HNSA) is 18.00 (data as of 2026-03-22).
Does Hansa Biopharma AB pay a dividend?
Dividend yield is not available in the current snapshot for Hansa Biopharma AB (HNSA). Check the MyAverix Finance app for the latest dividend data.
What sector is Hansa Biopharma AB in?
Hansa Biopharma AB (HNSA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is HNSA listed on?
HNSA is listed on ST.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.